References
- Woolf AD, Pfleger B. Burden of major musculoskeletal conditions. Bull World Health Organ 2003;81:646–56
- Jacobson L, Mariano AJ. General considerations of chronic pain. In: Loeser JD, Butler SH, Chapman CR, et al., eds. Bonica’s Management of Pain. Baltimore, MD: Lippincott Williams & Wilkins, 2001:241–54
- Rizzo JA, Abbott TA, III, Berger ML. The labor productivity effects of chronic backache in the United States. Med Care 1998;36:1471–88
- Feldman ER, Ting G. Chronic Low Back Pain. Decision Resources, Inc., 2005;ii–172
- Breivik H, Collett B, Ventafridda V, et al. Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment. Eur J Pain 2006;10:287–333
- Portenoy RK. Opioid therapy for chronic nonmalignant pain: clinician’s perspective. J Law Med Ethics 1996;24:296–309
- Jamison RN, Raymond SA, Slawsby ES, et al. Opioid therapy for chronic noncancer back pain. A randomized prospective study. Spine 1998;23:2591–600
- Ashburn MA, Staats PS. Management of chronic pain. Lancet 1999;353:1865–9
- Reisine T, Pasternak G. Opioid analgesics and antagonists. In: Hardman JG, Gilman AG, Limbird LE, eds. Goodman & Gilman’s The Pharmacological Basis of Therapeutics. New York, NY: McGraw-Hill, 1996:521–55
- Lipman AG. Clinically relevant differences among the opioid analgesics. Am J Hosp Pharm 1990;47:S7–13
- Shafer AL, Donnelly AJ. Management of postoperative pain by continuous epidural infusion of analgesics. Clin Pharm 1991;10:745–64
- Hale ME, Fleischmann R, Salzman R, et al. Efficacy and safety of controlled-release versus immediate-release oxycodone: randomized, double-blind evaluation in patients with chronic back pain. Clin J Pain 1999;15:179–83
- Hale ME, Dvergsten C, Gimbel J. Efficacy and safety of oxymorphone extended release in chronic low back pain: results of a randomized, double-blind, placebo- and active-controlled phase III study. J Pain 2005;6:21–8
- Angst MS, Drover DR, Lotsch J, et al. Pharmacodynamics of orally administered sustained-release hydromorphone in humans. Anesthesiology 2001;94:63–73
- Drover DR, Angst MS, Valle M, et al. Input characteristics and bioavailability after administration of immediate and a new extended-release formulation of hydromorphone in healthy volunteers. Anesthesiology 2002;97:827–36
- Quigley C, Wiffen P. A systematic review of hydromorphone in acute and chronic pain. J Pain Symptom Manage 2003;25:169–78
- Palangio M, Northfelt DW, Portenoy RK, et al. Dose conversion and titration with a novel, once-daily, OROS osmotic technology, extended-release hydromorphone formulation in the treatment of chronic malignant or nonmalignant pain. J Pain Symptom Manage 2002;23:355–68
- Roth S, Damask M, Khanna S, et al. To evaluate the efficacy and safety of OROS hydromorphone versus extended-release oxycodone for the management of moderate to severe chronic pain in patients with osteoarthritis of the knee or hip, regularly using NSAIDs with or without the addition of opioid analgesia. IASP Press 2005:247. Abstract 689–P295
- World Health Organization. Cancer pain relief and palliative care. Report of a WHO Expert Committee. Technical Report Series 804. Geneva, Switzerland: World Health Organization, 1990. 1–75
- Daut RL, Cleeland CS, Flanery RC. Development of the Wisconsin Brief Pain Questionnaire to assess pain in cancer and other diseases. Pain 1983;17:197–210
- Ware JE, Jr., Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30: 473–83
- Appendix: Actual Patient Assessment Questionaire (PAQ). Section 9. Your sleep. In: Stewart AL, Ware JE, eds. Measuring Functioning and Well-Being. Durham, NC: Duke University Press, 1992: 399–400
- Rashiq S, Koller M, Haykowsky M, et al. The effect of opioid analgesia on exercise test performance in chronic low back pain. Pain 2003;106:119–25
- Bartleson JD. Evidence for and against the use of opioid analgesics for chronic nonmalignant low back pain: a review. Pain Med 2002;3:260–71
- Murray A, Hagen NA. Hydromorphone. J Pain Symptom Manage 2005;29:S57–66
- Chou R, Clark E, Helfand M. Comparative efficacy and safety of long-acting oral opioids for chronic non-cancer pain: a systematic review. J Pain Symptom Manage 2003;26:1026–48